Clinical Trial Update: Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the combination of apalutamide with PET-guided targeted radiation for men with prostate cancer that has recurred after surgery; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Status: RECRUITING